# DOCETAXEL
> **NDA215813** · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2022-11-22
## Drug
- **FDA Application Number:** NDA215813
- **Application type:** New Drug Application
- **Brand name:** DOCETAXEL
- **Generic name:** DOCETAXEL
- **Active ingredients:** DOCETAXEL
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AVYXA HOLDINGS
- **Manufacturer:** Avyxa Pharma, LLC
- **First approval:** 2022-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215813)
---
*AI Analytics · CC0 1.0*